Ascendis Pharma A/S (ASND)

259.28 +2.69 (+1.05%) USD  |  NASDAQ  |  Nov 11, 16:00
260.39 +1.11 (+0.43%) After-Hours: 20:00
More

Ascendis Pharma Annual EPS Estimates

Annual EPS Estimates Chart

View Annual EPS Estimates for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual EPS Estimates Data

View and export this data back to 2026. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
Date Value
December 31, 2026 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

Annual EPS Estimates Range, Past 5 Years

View Annual EPS Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS Estimates Benchmarks

View Annual EPS Estimates Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Novo Nordisk A/S Upgrade
Genmab A/S Upgrade
Zealand Pharma A/S --
Evaxion AS Upgrade